Ascendis Pharma A (ASND) Debt Ratio (2021 - 2026)

Ascendis Pharma A has reported Debt Ratio for 6 years, with the latest figure at 0.37 in Q1 2026.

• Quarterly Debt Ratio fell 60.12% year-over-year to 0.37 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.37 (down 60.12% YoY) and the FY2025 annual result came in at 0.82, up 214.07% from the prior year.
• Debt Ratio eased to 0.37 in Q1 2026 per ASND's latest filing, from 0.82 in the prior quarter.
• Over five years, Debt Ratio peaked at 1.07 in Q2 2024 and troughed at 0.26 in Q4 2024.
• A 5-year average of 0.66 and a median of 0.64 in 2023 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio jumped 597.33% in 2022, then sank 65.7% in 2024.
• Over 5 years, Debt Ratio stood at 0.37 in 2022, then soared by 108.35% to 0.76 in 2023, then tumbled by 65.7% to 0.26 in 2024, then soared by 214.07% to 0.82 in 2025, then plunged by 55.15% to 0.37 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.37, 0.82, and 0.86 for Q1 2026, Q4 2025, and Q3 2025 respectively.